Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interferon-alpha.

PubWeight™: 1.03‹?› | Rank: Top 15%

🔗 View Article (PMID 10651835)

Published in Eur J Clin Invest on February 01, 2000

Authors

T Konrad1, S Zeuzem, P Vicini, G Toffolo, D Briem, J Lormann, G Herrmann, A Berger, K Kusterer, G Teuber, C Cobelli, K H Usadel

Author Affiliations

1: J.W. Goethe-University, Frankfurt, Germany.

Articles citing this

Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease. Gut (2007) 2.23

Insulin resistance and steatosis in hepatitis C virus infection. Gut (2005) 1.00

Hepatitis C virus infection and type 1 and type 2 diabetes mellitus. World J Diabetes (2014) 0.98

Diabetes mellitus during interferon therapy for chronic viral hepatitis. Dig Dis Sci (2002) 0.91

Seroprevalence of hepatitis C in type 2 diabetes: evidence for a positive association. Virol J (2010) 0.90

Clearance of HCV by Combination Therapy of Pegylated Interferon alpha-2a and Ribavirin Improves Insulin Resistance. Gut Liver (2009) 0.85

Hepatitis C Virus, Insulin Resistance, and Steatosis. J Clin Transl Hepatol (2016) 0.85

Simultaneous development of diabetic ketoacidosis and Hashitoxicosis in a patient treated with pegylated interferon-alpha for chronic hepatitis C. World J Gastroenterol (2007) 0.83

Modulation of PI3K-LXRα-dependent lipogenesis mediated by oxidative/nitrosative stress contributes to inhibition of HCV replication by quercetin. Lab Invest (2014) 0.83

Risk factors for new onset diabetes mellitus after liver transplantation: A meta-analysis. World J Gastroenterol (2015) 0.80

Hepatitis C Virus infection in apparentenly healthy individuals with family history of diabetes in Vom, Plateau State Nigeria. Virol J (2009) 0.79

Viruses and diabetes: is there something sweet about hepatitis C infection? Ochsner J (2001) 0.77

Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies. World J Exp Med (2012) 0.76

Abrupt onset of type 1 diabetes mellitus during recombinant interferon-alpha 2b therapy in a patient with chronic hepatitis B. World J Gastroenterol (2008) 0.75

Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review. World J Gastroenterol (2017) 0.75

Articles by these authors

On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun (1967) 18.32

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT) Lancet (1998) 9.78

Quantitative estimation of insulin sensitivity. Am J Physiol (1979) 7.37

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. N Engl J Med (1998) 6.23

Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest (1981) 5.82

Maturation of the immune response in germinal centers. Cell (1991) 5.68

Why doesn't audit work? BMJ (1998) 5.63

Private company wins rights to Icelandic gene database. BMJ (1999) 4.04

Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis. Aliment Pharmacol Ther (2014) 3.91

Mapping the active site of papain with the aid of peptide substrates and inhibitors. Philos Trans R Soc Lond B Biol Sci (1970) 3.29

On the active site of proteases. 3. Mapping the active site of papain; specific peptide inhibitors of papain. Biochem Biophys Res Commun (1968) 3.10

Computer-assisted prediction, classification, and delimitation of protein binding sites in nucleic acids. Nucleic Acids Res (1993) 3.06

Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity. Diabetes (2001) 3.05

Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy. Diabetologia (2010) 2.91

A mathematical analysis for indentation tests of articular cartilage. J Biomech (1972) 2.67

SAAM II: Simulation, Analysis, and Modeling Software for tracer and pharmacokinetic studies. Metabolism (1998) 2.65

A newly identified DNA ligase of Saccharomyces cerevisiae involved in RAD52-independent repair of DNA double-strand breaks. Genes Dev (1997) 2.61

NEJ1 controls non-homologous end joining in Saccharomyces cerevisiae. Nature (2001) 2.42

Silicon nanowire-based solar cells on glass: synthesis, optical properties, and cell parameters. Nano Lett (2009) 2.41

Amoxicillin pharmacokinetics in pregnant women: modeling and simulations of dosage strategies. Clin Pharmacol Ther (2007) 2.38

Endoscopic transhiatal drainage of a mediastinal pancreatic pseudocyst. Endoscopy (2004) 2.34

Global identifiability of nonlinear models of biological systems. IEEE Trans Biomed Eng (2001) 2.33

Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta-analysis. J Viral Hepat (2011) 2.30

Detection of Herpes simplex virus DNA by real-time PCR. J Clin Microbiol (2000) 2.29

Acetic acid-guided biopsies after magnifying endoscopy compared with random biopsies in the detection of Barrett's esophagus: a prospective randomized trial with crossover design. Gastrointest Endosc (2006) 2.28

Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med (1984) 2.26

Reduction of diagnostic window by new fourth-generation human immunodeficiency virus screening assays. J Clin Microbiol (1998) 2.25

Severe 25-hydroxyvitamin D deficiency identifies a poor prognosis in patients with hepatocellular carcinoma - a prospective cohort study. Aliment Pharmacol Ther (2014) 2.18

Generalized sensitivity functions in physiological system identification. Ann Biomed Eng (1999) 2.15

[Successful multiple resuscitation in flecainide poisoning]. Dtsch Med Wochenschr (1992) 2.04

Conformational studies of poly-L-alanine in water. Biopolymers (1968) 2.02

Position-dependent accommodative shift of retropupillary fixated iris-claw lenses. Graefes Arch Clin Exp Ophthalmol (2012) 2.00

The interfascicular nerve-grafting of the median and ulnar nerves. J Bone Joint Surg Am (1972) 1.82

Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia. Infect Immun (1996) 1.82

CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab (1997) 1.78

Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology. Hepatology (1996) 1.77

Pilonidal sinus disease. J Visc Surg (2013) 1.76

[Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection]. Z Gastroenterol (2010) 1.76

A telemedicine support for diabetes management: the T-IDDM project. Comput Methods Programs Biomed (2002) 1.69

Parameter and structural identifiability concepts and ambiguities: a critical review and analysis. Am J Physiol (1980) 1.69

Persistence of pedicle blood flow up to 10 years after free musculocutaneous tissue transfer. Plast Reconstr Surg (1998) 1.67

Quantitative estimation of beta cell sensitivity to glucose in the intact organism: a minimal model of insulin kinetics in the dog. Diabetes (1980) 1.67

Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. J Clin Invest (1993) 1.67

Microcirculatory changes in sodium taurocholate-induced pancreatitis in rats. Am J Physiol (1991) 1.65

Detection of residual hepatitis C virus RNA by transcription-mediated amplification in patients with complete virologic response according to polymerase chain reaction-based assays. Hepatology (2000) 1.64

On estimating recessive frequencies from truncated samples. Biometrics (1967) 1.62

Modular closed-loop control of diabetes. IEEE Trans Biomed Eng (2012) 1.61

Matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF) mass spectrometry as a tool for rapid diagnosis of potentially toxigenic Corynebacterium species in the laboratory management of diphtheria-associated bacteria. Euro Surveill (2010) 1.60

Right colonic involvement is associated with severe forms of ischemic colitis and occurs frequently in patients with chronic renal failure requiring hemodialysis. Am J Gastroenterol (2000) 1.59

Neonatal urinary uric acid/creatinine [correction of ceratinine] ratio as an additional marker of perinatal asphyxia. Eur J Pediatr (1995) 1.59

Cystic retroperitoneal lymphangiomas in adults. Eur J Surg Oncol (1997) 1.59

Direct assessment of liver glycogen storage by 13C nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects. J Clin Invest (1996) 1.57

Serum and lower respiratory tract drug concentrations after tobramycin inhalation in young children with cystic fibrosis. J Pediatr (2001) 1.56

Stability of the Astronomical Frequencies Over the Earth's History for Paleoclimate Studies. Science (1992) 1.54

Ovarian cancer identification based on dimensionality reduction for high-throughput mass spectrometry data. Bioinformatics (2005) 1.52

Methods for assessment of the rate of onset and offset of insulin action during nonsteady state in humans. Am J Physiol (1993) 1.52

The purification of papain by affinity chromatography. Eur J Biochem (1970) 1.52

Is the minimal model too minimal? Diabetologia (1996) 1.52

Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma. Am J Gastroenterol (1999) 1.51

Preterm infants with low immunoglobulin G levels have increased risk of neonatal sepsis but do not benefit from prophylactic immunoglobulin G. J Pediatr (2000) 1.51

High tie versus low tie vascular ligation of the inferior mesenteric artery in colorectal cancer surgery: impact on the gain in colon length and implications on the feasibility of anastomoses. Dis Colon Rectum (2012) 1.51

Exercise-induced myocardial ischemia in isolated coronary artery ectasias and aneurysms ("dilated coronopathy"). J Am Coll Cardiol (1999) 1.50

Differentiation between benign and malignant adrenal mass using contrast-enhanced ultrasound. Ultraschall Med (2011) 1.50

Effect of insulin on the distribution and disposition of glucose in man. J Clin Invest (1985) 1.49

Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. Clin Pharmacol Ther (2009) 1.48

Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes (1996) 1.46

Global identifiability of linear compartmental models--a computer algebra algorithm. IEEE Trans Biomed Eng (1998) 1.46

Biogenesis of purple membrane: regulation of bacterio-opsin synthesis. FEBS Lett (1976) 1.46

Malignant degeneration in Madelung's disease (benign lipomatosis of the neck): case report. Br J Plast Surg (1983) 1.46

Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin. J Viral Hepat (2013) 1.46

Minimal models of glucose disappearance: lessons from the labelled IVGTT. Diabet Med (1991) 1.45

Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa. Hepatology (1998) 1.45

IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C. J Hepatol (2011) 1.45

A case-control study of risk factors for intraoperative suprachoroidal expulsive hemorrhage. Ophthalmology (1991) 1.45

Comparison of metabolic and receptor imaging in recurrent medullary thyroid carcinoma with histopathological findings. Eur J Nucl Med (1998) 1.43

Hepatitis delta: on soft paws across Germany. Infection (2012) 1.43

Giant and reversible extrinsic magnetocaloric effects in La0.7Ca0.3MnO3 films due to strain. Nat Mater (2012) 1.43

Prevalence of hepatitis G virus and its strain variant, the GB agent, in blood donations and their transmission to recipients. Transfusion (1997) 1.42

Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment. Gut (2000) 1.42

Dynamics of hepatitis B virus quasispecies heterogeneity and virologic response in patients receiving low-to-moderate genetic barrier nucleoside analogs. J Viral Hepat (2012) 1.42

Assessment, by transcription-mediated amplification, of virologic response in patients with chronic hepatitis C virus treated with peginterferon alpha-2a. J Clin Microbiol (2001) 1.42

A retroviral long terminal repeat adjacent to the HLA DQB1 gene (DQ-LTR13) modifies Type I diabetes susceptibility on high risk DQ haplotypes. Diabetologia (2002) 1.41

Experience with split-course external beam irradiation +/- chemotherapy and integrated Ir-192 high-dose-rate brachytherapy in the treatment of primary carcinomas of the anal canal. Int J Radiat Oncol Biol Phys (2001) 1.41

Bicaval versus atrial anastomoses in cardiac transplantation. Right atrial dimension and tricuspid valve function at rest and during exercise up to thirty-six months after transplantation. J Thorac Cardiovasc Surg (1994) 1.41

[Orthotopic liver transplantation with arterial re-anastomosis in the rat--a detailed description of technique and analysis of possible errors]. Langenbecks Arch Chir (1993) 1.40

The subcutaneous route to insulin-dependent diabetes therapy. IEEE Eng Med Biol Mag (2001) 1.40

Profiling left and right ventricular proportional output during fetal life with a novel systolic index in the aortic isthmus. Ultrasound Obstet Gynecol (2014) 1.39

On the size of the active site in proteases. II. Carboxypeptidase-A. Biochem Biophys Res Commun (1967) 1.39

How accurate is serologic testing of plasma pools for hepatitis B virus surface antigen, anti-human immunodeficiency virus 1 and 2, and anti-hepatitis C virus? Infusionsther Transfusionsmed (1996) 1.39

HLA-DR2 and sleep onset REM periods in endogenous depression. Br J Psychiatry (1988) 1.38

The new paradigm of hepatitis C therapy: integration of oral therapies into best practices. J Viral Hepat (2013) 1.37